298 related articles for article (PubMed ID: 31764021)
41. Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology.
Detsky JS; Keith J; Conklin J; Symons S; Myrehaug S; Sahgal A; Heyn CC; Soliman H
J Neurooncol; 2017 Sep; 134(2):433-441. PubMed ID: 28674974
[TBL] [Abstract][Full Text] [Related]
42. Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases.
Ohtakara K; Hayashi S; Nakayama N; Ohe N; Yano H; Iwama T; Hoshi H
J Neurooncol; 2012 May; 108(1):201-9. PubMed ID: 22392126
[TBL] [Abstract][Full Text] [Related]
43. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
[TBL] [Abstract][Full Text] [Related]
44. Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors.
Moore A; Yust-Katz S; Icht O; Eliyahou R; Gordon N; Cohen AY; Goldstein IM; Peled N; Seigal T; Amiel A; Dudnik E
J Neurol Sci; 2021 Aug; 427():117556. PubMed ID: 34186494
[TBL] [Abstract][Full Text] [Related]
45. Border Zone Maybe Correlated with Radiation Necrosis After Radiosurgery in Metastatic Brain Tumor.
Lee C; Yoon SY; Hwang JH; Park SH; Kwon M; Yoon C; Lee K; Hahm MH; Park KS
World Neurosurg; 2024 Jun; 186():e374-e381. PubMed ID: 38561029
[TBL] [Abstract][Full Text] [Related]
46. Toward the complete control of brain metastases using surveillance screening and stereotactic radiosurgery.
Wolf A; Kvint S; Chachoua A; Pavlick A; Wilson M; Donahue B; Golfinos JG; Silverman J; Kondziolka D
J Neurosurg; 2018 Jan; 128(1):23-31. PubMed ID: 28298015
[TBL] [Abstract][Full Text] [Related]
47. Reirradiation With Stereotactic Radiosurgery After Local or Marginal Recurrence of Brain Metastases From Previous Radiosurgery.
Kowalchuk RO; Niranjan A; Lee CC; Yang HC; Liscak R; Guseynova K; Tripathi M; Kumar N; Peker S; Samanci Y; Hess J; Chiang V; Iorio-Morin C; Mathieu D; Pikis S; Wei Z; Lunsford LD; Trifiletti DM; Sheehan JP
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):726-734. PubMed ID: 34644606
[TBL] [Abstract][Full Text] [Related]
48. Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients.
Lehrer EJ; Khosla AA; Ozair A; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Mathieu D; Trudel C; Deibert CP; Malouff TD; Ruiz-Garcia H; Peterson JL; Patel S; Bonney P; Hwang L; Yu C; Zada G; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Fakhoury KR; Rusthoven CG; Dickstein DR; Sheehan JP; Trifiletti DM; Ahluwalia MS
J Neurooncol; 2023 Oct; 165(1):63-77. PubMed ID: 37889444
[TBL] [Abstract][Full Text] [Related]
49. BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis.
Patel KR; Chowdhary M; Switchenko JM; Kudchadkar R; Lawson DH; Cassidy RJ; Prabhu RS; Khan MK
Melanoma Res; 2016 Aug; 26(4):387-94. PubMed ID: 27223498
[TBL] [Abstract][Full Text] [Related]
50. Laser-interstitial thermal therapy compared to craniotomy for treatment of radiation necrosis or recurrent tumor in brain metastases failing radiosurgery.
Hong CS; Deng D; Vera A; Chiang VL
J Neurooncol; 2019 Apr; 142(2):309-317. PubMed ID: 30656529
[TBL] [Abstract][Full Text] [Related]
51. Imaging changes over 18 months following stereotactic radiosurgery for brain metastases: both late radiation necrosis and tumor progression can occur.
Fujimoto D; von Eyben R; Gibbs IC; Chang SD; Li G; Harsh GR; Hancock S; Fischbein N; Soltys SG
J Neurooncol; 2018 Jan; 136(1):207-212. PubMed ID: 29098569
[TBL] [Abstract][Full Text] [Related]
52. Post-stereotactic radiosurgery brain metastases: a review.
Fabiano AJ; Qiu J
J Neurosurg Sci; 2015 Jun; 59(2):157-67. PubMed ID: 25600555
[TBL] [Abstract][Full Text] [Related]
53. Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases.
Mohammadi AM; Schroeder JL; Angelov L; Chao ST; Murphy ES; Yu JS; Neyman G; Jia X; Suh JH; Barnett GH; Vogelbaum MA
J Neurosurg; 2017 Mar; 126(3):735-743. PubMed ID: 27231978
[TBL] [Abstract][Full Text] [Related]
54. Reenlargement of radiation necrosis after stereotactic radiotherapy for brain metastasis from lung cancer during bevacizumab treatment.
Furuuchi K; Nishiyama A; Yoshioka H; Yokoyama T; Ishida T
Respir Investig; 2017 Mar; 55(2):184-187. PubMed ID: 28274537
[TBL] [Abstract][Full Text] [Related]
55. Definitive chemoradiation therapy following surgical resection or radiosurgery plus whole-brain radiation therapy in non-small cell lung cancer patients with synchronous solitary brain metastasis: a curative approach.
Parlak C; Mertsoylu H; Güler OC; Onal C; Topkan E
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):885-91. PubMed ID: 24495594
[TBL] [Abstract][Full Text] [Related]
56. Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts.
Li J; He J; Cai L; Lai M; Hu Q; Ren C; Wen L; Wang J; Zhou J; Zhou Z; Li S; Ye M; Shan C; Chen L; Zhou C
Ann Palliat Med; 2021 Feb; 10(2):2018-2026. PubMed ID: 33549015
[TBL] [Abstract][Full Text] [Related]
57. Risk of radiation necrosis after hypofractionated stereotactic radiotherapy (HFSRT) for brain metastases: a single center retrospective study.
Di Perri D; Tanguy R; Malet C; Robert A; Sunyach MP
J Neurooncol; 2020 Sep; 149(3):447-453. PubMed ID: 32979130
[TBL] [Abstract][Full Text] [Related]
58. Stereotactic irradiation of non-small cell lung cancer brain metastases: evaluation of local and cerebral control in a large series.
Fessart E; Mouttet Audouard R; Le Tinier F; Coche-Dequeant B; Lacornerie T; Tresch E; Scherpereel A; Lartigau E; Mirabel X; Pasquier D
Sci Rep; 2020 Jul; 10(1):11201. PubMed ID: 32641798
[TBL] [Abstract][Full Text] [Related]
59. Trastuzumab emtansine increases the risk of stereotactic radiosurgery-induced radionecrosis in HER2 + breast cancer.
Id Said B; Chen H; Jerzak KJ; Warner E; Myrehaug S; Tseng CL; Detsky J; Husain Z; Sahgal A; Soliman H
J Neurooncol; 2022 Aug; 159(1):177-183. PubMed ID: 35715667
[TBL] [Abstract][Full Text] [Related]
60. Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis.
Patel KR; Burri SH; Boselli D; Symanowski JT; Asher AL; Sumrall A; Fraser RW; Press RH; Zhong J; Cassidy RJ; Olson JJ; Curran WJ; Shu HG; Crocker IR; Prabhu RS
J Neurooncol; 2017 Feb; 131(3):611-618. PubMed ID: 28000105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]